Home » Topics » Regulatory » EMA

EMA
RSS

FDA and EMA to review vandetanib for advanced medullary thyroid cancer

Sep. 27, 2010

EMA updates nevirapine label for patients with HIV-1 infection

Sep. 21, 2010

Novartis Europharm withdraws Rasival MAA for essential hypertension

Sep. 21, 2010

GSK investigates reports of narcolepsy following Pandemrix vaccination

Sep. 6, 2010

MSD's Sycrest approved in Europe for biopolar disorder

Sep. 3, 2010

FDA approves Bionovo's CMC plan for Menerba

Aug. 31, 2010

EMA investigates potential relationship between Pandemrix and narcolepsy

Aug. 30, 2010

European Commission updates license for Cervarix HPV vaccine

Aug. 30, 2010

Shire's VPRIV approved in Europe for type 1 Gaucher's disease

Aug. 27, 2010

Bristol-Myers Squibb offers pipeline update for Q2 2010

Aug. 24, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...